Pneumonia and COVID-19 in Mexico

Authors

  • Nicolás Padilla-Raygoza Department of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Guanajuato, México.
  • Gilberto Flores-Vargas Department of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Guanajuato, México.
  • María de Jesús Gallardo-Luna Department of Research and Technological Development, Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Guanajuato, México.
  • Efrain Navarro-Olivos Directorate of Teaching and Research, Institute of Public Health from Guanajuato State, Guanajuato, Guanajuato, México.
  • Elia Lara-Lona Department of Medicine and Nutrition, Division of Health Sciences, Campus León, University of Guanajuato, León, Guanajuato, México.
  • Francisco J. Magos-Vázquez Directorate of Services on Health, Institute of Public Health from Guanajuato State, Guanajuato, Guanajuato, México.
  • Daniel Alberto Díaz-Martínez Directorate of Services on Health, Institute of Public Health from Guanajuato State, Guanajuato, Guanajuato, México.

DOI:

https://doi.org/10.9734/bpi/idmmr/v11/2289C

Keywords:

SARS-CoV-2, Covid-19, pneumonia, mortality

Abstract

In this chapter, we present a review of the SARS-CoV-2 and COVID-19 presence among the Mexican population. We also show the effect of pneumonia in people with COVID-19 whose outcome was fatal so far.

For all age groups, pneumonia is one of the leading causes of death among patients diagnosed with COVID-19. It is more frequent because SARS-CoV-2 uses the ACE receptor to enter epithelial cells primarily in the respiratory tract.  All ages, from the Mexican population, had pneumonia as a significant risk factor to die due to COVID-19.

In the Mexican population under 19 years of age, a positive correlation and linear relationship between pneumonia and Case Fatality Ratio r=0.79, CFR(%)=0.02 + 0.29 cases with pneumonia(%), t=0.68, P-value=.0001.

In conclusion, pneumonia is a leading cause of death in patients with COVID-19.

Published

2022-03-07

How to Cite

Nicolás Padilla-Raygoza, Gilberto Flores-Vargas, María de Jesús Gallardo-Luna, Efrain Navarro-Olivos, Elia Lara-Lona, Francisco J. Magos-Vázquez, & Daniel Alberto Díaz-Martínez. (2022). Pneumonia and COVID-19 in Mexico. Issues and Developments in Medicine and Medical Research Vol. 11, 9–17. https://doi.org/10.9734/bpi/idmmr/v11/2289C

Issue

Issues and Developments in Medicine and Medical Research Vol. 11

Section

Chapters